i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)

Jun 24, 2024

Time to read 4 Minutes

Download PDF

Back